CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $6.29M invested in Celyad Oncology SA American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
KI
Kapitalo Investimentos
Sao Paulo,
Brazil
|
+$29.8K |
2 |
TSS
Two Sigma Securities
New York
|
+$10.6K |
Top Sellers
1 |
Morgan Stanley
New York
|
-$17.5K |
2 |
Citadel Advisors
Miami,
Florida
|
-$12.7K |
3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$8.04K |
4 |
Millennium Management
New York
|
-$5K |
5 |
UBS Group
Zurich,
Switzerland
|
-$3.51K |